An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

被引:237
作者
Klein, PA [1 ]
Clark, RAF [1 ]
机构
[1] SUNY Stony Brook, Sch Med, Dept Dermatol, Stony Brook, NY 11794 USA
关键词
D O I
10.1001/archderm.135.12.1522
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To critically review the body of clinical trials that refute or support the efficacy of antihistamines in relieving pruritus in patients with atopic dermatitis. Design: Review of MEDLINE from 1966 through March 1999, the Cochrane Database of Systematic Reviews, and Best Evidence to identify therapeutic trials of antihistamines in patients with atopic dermatitis. Main Outcome Measures: All randomized controlled trials or clinical trials of antihistamines used in the treatment of atopic dermatitis. We found 16 studies throughout the literature. Results: Large, randomized, double-blind, placebo-controlled clinical trials with definitive conclusions (grade A trials) have not been performed. Two grade B trials (small, rigorous, randomized trials with uncertain results due to moderate to high alpha or beta error) refuted the use of antihistamines in relieving pruritus. One grade B trial supported the efficacy of antihistamines in relieving pruritus. All remaining trials (grade C) lacked placebo controls or randomization, or contained fewer than 20 patients in each treatment group. Conclusions: Although antihistamines are often used in the treatment of atopic dermatitis, little objective evidence exists to demonstrate relief of pruritus. The majority of trials are flawed in terms of the sample size or study design. Based on the literature alone, the efficacy of antihistamines remains to be adequately investigated. Anecdotally, sedating antihistamines have sometimes been useful by virtue of their soporific effect and bedtime use may be warranted. There is no evidence to support the effectiveness of expensive nonsedating agents.
引用
收藏
页码:1522 / 1525
页数:4
相关论文
共 26 条
[1]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[2]   HISTAMINE, ANTIHISTAMINES AND ATOPIC ECZEMA [J].
BEHRENDT, H ;
RING, J .
CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 :25-30
[3]   FAILURE OF TERFENADINE IN RELIEVING THE PRURITUS OF ATOPIC-DERMATITIS [J].
BERTHJONES, J ;
GRAHAMBROWN, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 121 (05) :635-637
[4]   TREATMENT OF ITCHING IN ATOPIC ECZEMA WITH ANTIHISTAMINES WITH A LOW SEDATIVE PROFILE [J].
DOHERTY, V ;
SYLVESTER, DGH ;
KENNEDY, CTC ;
HARVEY, SG ;
CALTHROP, JG ;
GIBSON, JR .
BRITISH MEDICAL JOURNAL, 1989, 298 (6666) :96-96
[5]   A DOUBLE-BLIND TRIAL OF THE H-2-RECEPTOR ANTAGONIST CIMETIDINE, AND THE H-1 RECEPTOR ANTAGONIST PROMETHAZINE HYDROCHLORIDE IN THE TREATMENT OF ATOPIC-DERMATITIS [J].
FOULDS, IS ;
MACKIE, RM .
CLINICAL ALLERGY, 1981, 11 (04) :319-323
[6]   A DOUBLE-BLIND TRIAL OF H1-RECEPTOR AND H2-RECEPTOR ANTAGONISTS IN THE TREATMENT OF ATOPIC-DERMATITIS [J].
FROSCH, PJ ;
SCHWANITZ, HJ ;
MACHER, E .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1984, 276 (01) :36-40
[7]  
HANNUKSELA M, 1993, ANN ALLERGY, V70, P127
[8]   SKIN HISTAMINE LEVELS IN CHRONIC ATOPIC DERMATITIS [J].
JOHNSON, HH ;
DEOREO, GA ;
LASCHEID, WP ;
MITCHELL, F .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1960, 34 (04) :237-238
[9]  
JUHLIN L, 1967, ACTA DERM-VENEREOL, V47, P383
[10]  
KLEIN GL, 1980, ANN ALLERGY, V44, P142